📊 SNPS Key Takeaways
Is Synopsys Inc. (SNPS) a Good Investment?
Synopsys demonstrates strong revenue growth (+15.1% YoY) and exceptional cash generation (34.1% FCF margin), with a fortress balance sheet and healthy liquidity position. However, profitability metrics are concerning with collapsing net income (-0.1% YoY), diluted EPS down 44.6% YoY, and net margin compressed to 2.7% despite strong gross margins, suggesting operational challenges that require monitoring.
Synopsys shows strong top-line momentum, excellent gross margins, and outstanding free cash flow conversion, which points to a high-quality core software business. However, the latest period shows a sharp drop in diluted EPS and very weak net profitability relative to revenue, suggesting margin pressure, integration costs, or other below-the-line headwinds that reduce near-term fundamental strength. The balance sheet remains healthy overall, but improving operating leverage and earnings quality are the main conditions for a stronger outlook.
Why Buy Synopsys Inc. Stock? SNPS Key Strengths
- Strong revenue growth of 15.1% YoY demonstrates market demand and business expansion
- Exceptional free cash flow generation at $821.5M with 34.1% FCF margin indicates efficient core operations
- Fortress balance sheet with $30.5B equity, 0.33x debt-to-equity ratio, and 153.4x interest coverage providing financial flexibility
- High gross margin of 73.5% reflects strong pricing power and product differentiation
- Solid liquidity with 1.36x current ratio and $2.1B cash position
- Revenue growth remains strong at 15.1% YoY, indicating durable demand.
- Gross margin of 73.5% and FCF margin of 34.1% reflect a high-quality software model with strong cash generation.
- Liquidity is solid and leverage appears manageable, supported by a 1.36x current ratio and very high interest coverage.
SNPS Stock Risks: Synopsys Inc. Investment Risks
- Net income essentially flat YoY despite 15.1% revenue growth, indicating margin compression and operational inefficiency
- Diluted EPS collapsed 44.6% YoY, signaling significant shareholder value destruction from increased shares or non-operating charges
- Operating margin of 8.4% is thin relative to gross margin of 73.5%, suggesting high operating expenses consuming most gross profit
- Net margin of only 2.7% leaves minimal buffer for any adverse business developments or economic headwinds
- Return on equity (0.2%) and ROA (0.1%) are extremely poor relative to equity and asset base, indicating poor capital deployment efficiency
- Operating margin of 8.4% and net margin of 2.7% are weak relative to the company’s gross profitability.
- Diluted EPS fell 44.6% YoY, signaling significant pressure on bottom-line earnings quality.
- ROE and ROA are extremely low, raising concerns about capital efficiency on a very large asset base.
Key Metrics to Watch
- Operating margin trend - need to see expansion above 8.4% to justify premium valuation
- Net income growth reconciliation - critical to understand whether profit decline is operational or non-recurring
- Free cash flow sustainability - monitor if 34.1% FCF margin can be maintained as revenue growth moderates
- Operating expense ratio - track whether SG&A and R&D spending normalize or remain elevated
- Return on invested capital - improve ROIC metrics to demonstrate effective use of $30.5B equity base
- Operating margin and net margin recovery
- Diluted EPS growth relative to revenue growth
Synopsys Inc. (SNPS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 34.1% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments.
SNPS Profit Margin, ROE & Profitability Analysis
SNPS vs Technology Sector: How Synopsys Inc. Compares
How Synopsys Inc. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Synopsys Inc. Stock Overvalued? SNPS Valuation Analysis 2026
Based on fundamental analysis, Synopsys Inc. shows some fundamental concerns relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Synopsys Inc. Balance Sheet: SNPS Debt, Cash & Liquidity
SNPS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Synopsys Inc.'s revenue has grown significantly by 68% over the 5-year period, indicating strong business expansion. The most recent EPS of $7.92 reflects profitable operations.
SNPS Revenue Growth, EPS Growth & YoY Performance
SNPS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.5B | $65.0M | $0.34 |
| Q3 2025 | $1.5B | $242.5M | $1.50 |
| Q2 2025 | $1.5B | $292.1M | $1.88 |
| Q1 2025 | $1.5B | $295.7M | $1.89 |
| Q3 2024 | $1.4B | $336.3M | $2.17 |
| Q2 2024 | $1.3B | $272.9M | $1.76 |
| Q1 2024 | $1.4B | $271.5M | $1.75 |
| Q3 2023 | $1.2B | $222.6M | $1.43 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Synopsys Inc. Dividends, Buybacks & Capital Allocation
SNPS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Synopsys Inc. (CIK: 0000883241)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SNPS
What is the AI rating for SNPS?
Synopsys Inc. (SNPS) has a Combined AI Rating of BUY from Claude (BUY) and ChatGPT (HOLD) with 74% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are SNPS's key strengths?
Claude: Strong revenue growth of 15.1% YoY demonstrates market demand and business expansion. Exceptional free cash flow generation at $821.5M with 34.1% FCF margin indicates efficient core operations. ChatGPT: Revenue growth remains strong at 15.1% YoY, indicating durable demand.. Gross margin of 73.5% and FCF margin of 34.1% reflect a high-quality software model with strong cash generation..
What are the risks of investing in SNPS?
Claude: Net income essentially flat YoY despite 15.1% revenue growth, indicating margin compression and operational inefficiency. Diluted EPS collapsed 44.6% YoY, signaling significant shareholder value destruction from increased shares or non-operating charges. ChatGPT: Operating margin of 8.4% and net margin of 2.7% are weak relative to the company’s gross profitability.. Diluted EPS fell 44.6% YoY, signaling significant pressure on bottom-line earnings quality..
What is SNPS's revenue and growth?
Synopsys Inc. reported revenue of $2.4B.
Does SNPS pay dividends?
Synopsys Inc. does not currently pay dividends.
Where can I find SNPS SEC filings?
Official SEC filings for Synopsys Inc. (CIK: 0000883241) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SNPS's EPS?
Synopsys Inc. has a diluted EPS of $0.34.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is SNPS a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Synopsys Inc. has a BUY rating with 74% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is SNPS stock overvalued or undervalued?
Valuation metrics for SNPS: ROE of 0.2% (sector avg: 22%), net margin of 2.7% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy SNPS stock in 2026?
Our dual AI analysis gives Synopsys Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SNPS's free cash flow?
Synopsys Inc.'s operating cash flow is $856.8M, with capital expenditures of $35.3M. FCF margin is 34.1%.
How does SNPS compare to other Technology stocks?
Vs Technology sector averages: Net margin 2.7% (avg: 18%), ROE 0.2% (avg: 22%), current ratio 1.36 (avg: 2.5).